Editorial
doi: 10.1200/JCO.2009.24.5985.
Epub 2009 Nov 9.
Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected]
- PMID: 19901101
- DOI: 10.1200/JCO.2009.24.5985
Item in Clipboard
Editorial
Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected]
J Clin Oncol.
.
Erratum in
- J Clin Oncol. 2010 Mar 10;28(8):1439
No abstract available
Comment on
-
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.J Clin Oncol. 2009 Dec 10;27(35):5881-6. doi: 10.1200/JCO.2009.24.1034. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901104 Free PMC article. Clinical Trial.
-
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.J Clin Oncol. 2009 Dec 10;27(35):5874-80. doi: 10.1200/JCO.2009.23.6497. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901110 Clinical Trial.
Similar articles
-
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.J Clin Oncol. 2009 Dec 10;27(35):5874-80. doi: 10.1200/JCO.2009.23.6497. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901110 Clinical Trial.
-
Regimen of procarbazine, lomustine, and vincristine versus temozolomide for gliomas.Cancer. 2018 Jul 1;124(13):2674-2676. doi: 10.1002/cncr.31371. Epub 2018 Apr 26. Cancer. 2018. PMID: 29698549 No abstract available.
-
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.J Clin Oncol. 2009 Dec 10;27(35):5881-6. doi: 10.1200/JCO.2009.24.1034. Epub 2009 Nov 9. J Clin Oncol. 2009. PMID: 19901104 Free PMC article. Clinical Trial.
-
Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.Cancer Invest. 2007 Dec;25(8):776-84. doi: 10.1080/07357900701509403. Epub 2007 Oct 18. Cancer Invest. 2007. PMID: 17952745 Review.
-
[Clinicopathological diagnosis of gliomas by genotype analysis].Brain Nerve. 2009 Jul;61(7):773-80. Brain Nerve. 2009. PMID: 19618854 Review. Japanese.
Cited by
-
MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.Oncotarget. 2014 Dec 30;5(24):12908-15. doi: 10.18632/oncotarget.2679. Oncotarget. 2014. PMID: 25415048 Free PMC article.
-
The emerging role of galectins in high-fatality cancers.Cell Mol Life Sci. 2018 Apr;75(7):1215-1226. doi: 10.1007/s00018-017-2708-5. Epub 2017 Nov 8. Cell Mol Life Sci. 2018. PMID: 29119229 Free PMC article. Review.
-
Identifying the association of contrast enhancement with vascular endothelia growth factor expression in anaplastic gliomas: a volumetric magnetic resonance imaging analysis.PLoS One. 2015 Mar 30;10(3):e0121380. doi: 10.1371/journal.pone.0121380. eCollection 2015. PLoS One. 2015. PMID: 25823012 Free PMC article.
-
Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology).Neuro Oncol. 2012 Jun;14(6):798-807. doi: 10.1093/neuonc/nos081. Epub 2012 Apr 25. Neuro Oncol. 2012. PMID: 22539339 Free PMC article.
-
MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas.Clin Cancer Res. 2023 Nov 1;29(21):4399-4407. doi: 10.1158/1078-0432.CCR-23-1295. Clin Cancer Res. 2023. PMID: 37611077 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
